Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Novartis announced today that the US Food and Drug Administration FDA approved Pluvicto lutetium Lu vipivotide tetraxetan for patients with prostatespecific membrane antigen PSMApositive metastatic castrationresistant prostate cancer mCRPC who have...
BridgeBio Pharma Inc a new type of biopharmaceutical company focused on genetic diseases today announced the Japanese Ministry of Health Labour and Welfare has approved acoramidis under the brand name Beyonttra for the treatment of adults with transt...
Genmab AStoday announced that the Japan Ministry of Health Labour and Welfare has approved TIVDAK tisotumab vedotin for the treatment of advanced or recurrent cervical cancer that has progressed on or after cancer chemotherapy TIVDAK is the first and...
Celltrion Inc today announced that STEQEYMA ustekinumabstba a biosimilar to STELARA ustekinumab has been added to the Costco Member Prescription Program
Shionogi Co Ltdsubmitted today supplemental New Drug Application sNDA in Japan for its investigational oral antiviral ensitrelvir Generic name ensitrelvir fumaric acid Code No S hereafter ensitrelvir for postexposure prophylaxis
BioThera Solutions a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars and Dr Reddys Laboratories SA whollyowned subsidiary of Dr Reddys Laboratories Ltd
Gene Solutions a leading biotech company in Asia proudly announces a groundbreaking achievement in cancer early detection The companys innovative SPOTMAS test has become the first multicancer screening blood test in Asia
Diabetic wounds often lead to severe complications that can result in amputations These chronic and nonhealing wounds are marked by persistent inflammation affecting more than six per cent of the global population
Charles River Laboratories International Incand Valo Health Inc today announced the identification of an advanceable product candidate for the treatment of different forms of lupus and other autoimmune indications with significant unmet need
Xcell Biosciences Australia Pty Ltd Xcellbio an Australian affiliate of the San Franciscobased instrumentation company focused on cell and gene therapy applications has announced that it has entered into an agreement with the Royal Perth Hospital
